Abstract

TRIM24 (Tripartite Motif Containing 24) is a recently identified oncogene overexpressed in various cancers. However, the molecular mechanism of TRIM24 in the progression of head and neck squamous cell carcinoma (HNSCC) remains ambiguous. In the present study, we analyzed the expression pattern of TRIM24 in 100 HNSCC tissues and found that TRIM24 was overexpressed in 43/100 HNSCC cases. Significant association was found between TRIM24 overexpression and tumor-node-metastasis (TNM) stage (p = 0.0034) and T stage (p = 0.0048). Furthermore, we overexpressed and knocked down TRIM24 in Detroit 562 and FaDu cell lines, respectively. TRIM24 overexpression promoted proliferation, colony formation, and invasion, while TRIM24 depletion inhibited proliferation, colony formation, and invasion. Further studies showed that TRIM24 facilitated cell cycle transition and upregulated cyclin D1 and p-Rb. In addition, we found that GLUT3, a key protein involved in regulating glucose metabolism, was altered in HNSCC cells overexpressing TRIM24. We demonstrated that TRIM24 overexpression increased glucose uptake ATP production. Overexpression of TRIM24 increases cell sensitivity to glucose deprivation in Detroit cells. Depleting TRIM24 in FaDu cells demonstrated the opposite results. We also showed that TRIM24 could bind to the promoter region of cyclin D1. In conclusion, TRIM24 is upregulated in HNSCC and promotes HNSCC cell growth and invasion through modulation of cell cycle, glucose metabolism, and GLUT3, making TRIM24 a potential oncoprotein in HNSCC.

Highlights

  • Laryngeal carcinoma is a common head and neck cancer, with more than 150 thousand new cases recorded and 82 thousand deaths estimated in 2008 [1]

  • Moderate and strong TRIM24 overexpression were observed in 43% (43/100) of head and neck squamous cell carcinoma (HNSCC) tissues examined (Figures 1(b)–1(d))

  • Our results demonstrated that TRIM24 overexpression enhanced glucose consumption and ATP production, suggesting enhanced glucose metabolism induced by TRIM24

Read more

Summary

Introduction

Laryngeal carcinoma is a common head and neck cancer, with more than 150 thousand new cases recorded and 82 thousand deaths estimated in 2008 [1]. Treatments for laryngeal carcinoma including chemotherapy and radiotherapy greatly improved patient survival. It is reported that TRIM24 is involved in oncoprotein fusion by chromosome translocation in various cancers including leukemia, thyroid carcinoma, and myeloproliferative syndrome [6, 8]. It is overexpressed in human breast cancer and correlated with poor patient prognosis [9, 10], indicating a potentially oncogenic function for TRIM24 in human cancers. We investigated the effect of TRIM24 on proliferation and invasion of HNSCC cells and explored possible mechanisms

Materials and Methods
Results
Discussion
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call